ST Jingfeng: The restructuring plan will increase every 10 shares by 10 shares.

ST Jingfeng announcement, the restructuring plan will take Jingfeng Pharmaceutical's existing share capital of 880 million shares as the base, and implement the conversion of capital reserve into shares at a ratio of 10 shares for every 10 shares, totaling 880 million shares to be converted. After the conversion, Jingfeng Pharmaceutical's total share capital will increase to 1.76 billion shares. The aforementioned 880 million shares to be converted will no longer be distributed to original shareholders, but will be used exclusively to introduce restructuring investors. The restructuring investors will provide funding for subscription, and the corresponding funds will be used to pay bankruptcy costs, settle various debts, and supplement the company's working capital according to the provisions of the restructuring plan.